Invention Grant
- Patent Title: Stable silk fibroin based pharmaceutical formulations
-
Application No.: US16453597Application Date: 2019-06-26
-
Publication No.: US10987294B2Publication Date: 2021-04-27
- Inventor: Gregory H. Altman , Rebecca L. Lacouture , Rachel Lee Dow , Rachel M. Lind , Dylan S. Haas
- Applicant: Evolved by Nature, Inc.
- Applicant Address: US MA Medford
- Assignee: Evolved by Nature, Inc.
- Current Assignee: Evolved by Nature, Inc.
- Current Assignee Address: US MA Medford
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K8/02 ; A61K38/01 ; A61K8/64 ; C07K1/12 ; C07K14/435 ; A61K38/00 ; A61K8/98 ; A61Q19/02 ; A61K8/92 ; A61K8/04 ; A61K8/19 ; A61K8/9789 ; A61K8/9794 ; A61K8/97 ; A61K8/27 ; A61K8/29 ; A61K8/67 ; A61K8/73 ; A61Q17/04 ; A61Q19/00 ; A61Q19/08 ; A45D33/00 ; A61K8/365 ; A61K8/49

Abstract:
A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.
Public/Granted literature
- US20190380944A1 Stable Silk Protein Fragment Compositions Public/Granted day:2019-12-19
Information query